VCAM1 and cancer: VCAM‐1 targeted delivery of liposomes loaded with a CCR2 antagonist enabled specific delivery to the cancer cell‐activated endothelium36 In addition, lipid micelles composed of PEG‐distearoylphosphatidylethanolamine have high biocompatibility and can solubilize hydrophobic CCR2 inhibitors.37